Candesartan Cilexetil In Vitro–In Vivo Correlation: Predictive Dissolution as a Development Tool
The main objective of this investigation was to develop an in vitro–in vivo correlation (IVIVC) for immediate release candesartan cilexetil formulations by designing an in vitro dissolution test to be used as development tool. The IVIVC could be used to reduce failures in future bioequivalence studi...
| Autores: | , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Fecha de publicación: | 2020 |
| País: | España |
| Institución: | Universidad Miguel Hernández de Elche |
| Repositorio: | REDIUMH. Depósito Digital de la UMH |
| OAI Identifier: | oai:dspace.umh.es:11000/34728 |
| Acceso en línea: | https://hdl.handle.net/11000/34728 |
| Access Level: | acceso abierto |
| Palabra clave: | candesartan cilexetil IVIVC bioequivalence BCS predictive in vivo-dissolution CDU::6 - Ciencias aplicadas::62 - Ingeniería. Tecnología |
| id |
ES_51db0b79162f082c32a6084c74eec708 |
|---|---|
| oai_identifier_str |
oai:dspace.umh.es:11000/34728 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
Candesartan Cilexetil In Vitro–In Vivo Correlation: Predictive Dissolution as a Development ToolFigueroa-Campos, Andrés IgnacioSánchez-Dengra, BárbaraMerino, VirginiaDahan, ArikGonzalez-Alvarez, IsabelGarcía Arieta, AlfredoGonzalez-Alvarez, MartaBermejo, Marivalcandesartan cilexetilIVIVCbioequivalenceBCSpredictive in vivo-dissolutionCDU::6 - Ciencias aplicadas::62 - Ingeniería. TecnologíaThe main objective of this investigation was to develop an in vitro–in vivo correlation (IVIVC) for immediate release candesartan cilexetil formulations by designing an in vitro dissolution test to be used as development tool. The IVIVC could be used to reduce failures in future bioequivalence studies. Data from two bioequivalence studies were scaled and combined to obtain the dataset for the IVIVC. Two-step and one-step approaches were used to develop the IVIVC. Experimental solubility and permeability data confirmed candesartan cilexetil. Biopharmaceutic Classification System (BCS) class II candesartan average plasma profiles were deconvoluted by the Loo-Riegelman method to obtain the oral fractions absorbed. Fractions dissolved were obtained in several conditions in USP II and IV apparatus and the results were compared calculating the f2 similarity factor. Levy plot was constructed to estimate the time scaling factor and to make both processes, dissolution and absorption, superimposable. The in vitro dissolution experiment that reflected more accurately the in vivo behavior of the products of candesartan cilexetil employed the USP IV apparatus and a three-step pH buffer change, from 1.2 to 4.5 and 6.8, with 0.2% of Tween 20. This new model was able to predict the in vivo differences in dissolution and it could be used as a risk-analysis tool for formulation selection in future bioequivalence trials.MDPIDepartamentos de la UMH::Ingeniería202520252020info:eu-repo/semantics/articleapplication/pdf21application/pdfhttps://hdl.handle.net/11000/34728reponame:REDIUMH. Depósito Digital de la UMHinstname:Universidad Miguel Hernández de ElcheIngléshttps://doi.org/10.3390/pharmaceutics12070633info:eu-repo/semantics/openAccessAttribution-NonCommercial-NoDerivatives 4.0 Internacionalhttp://creativecommons.org/licenses/by-nc-nd/4.0/oai:dspace.umh.es:11000/347282026-05-27T13:36:21Z |
| dc.title.none.fl_str_mv |
Candesartan Cilexetil In Vitro–In Vivo Correlation: Predictive Dissolution as a Development Tool |
| title |
Candesartan Cilexetil In Vitro–In Vivo Correlation: Predictive Dissolution as a Development Tool |
| spellingShingle |
Candesartan Cilexetil In Vitro–In Vivo Correlation: Predictive Dissolution as a Development Tool Figueroa-Campos, Andrés Ignacio candesartan cilexetil IVIVC bioequivalence BCS predictive in vivo-dissolution CDU::6 - Ciencias aplicadas::62 - Ingeniería. Tecnología |
| title_short |
Candesartan Cilexetil In Vitro–In Vivo Correlation: Predictive Dissolution as a Development Tool |
| title_full |
Candesartan Cilexetil In Vitro–In Vivo Correlation: Predictive Dissolution as a Development Tool |
| title_fullStr |
Candesartan Cilexetil In Vitro–In Vivo Correlation: Predictive Dissolution as a Development Tool |
| title_full_unstemmed |
Candesartan Cilexetil In Vitro–In Vivo Correlation: Predictive Dissolution as a Development Tool |
| title_sort |
Candesartan Cilexetil In Vitro–In Vivo Correlation: Predictive Dissolution as a Development Tool |
| dc.creator.none.fl_str_mv |
Figueroa-Campos, Andrés Ignacio Sánchez-Dengra, Bárbara Merino, Virginia Dahan, Arik Gonzalez-Alvarez, Isabel García Arieta, Alfredo Gonzalez-Alvarez, Marta Bermejo, Marival |
| author |
Figueroa-Campos, Andrés Ignacio |
| author_facet |
Figueroa-Campos, Andrés Ignacio Sánchez-Dengra, Bárbara Merino, Virginia Dahan, Arik Gonzalez-Alvarez, Isabel García Arieta, Alfredo Gonzalez-Alvarez, Marta Bermejo, Marival |
| author_role |
author |
| author2 |
Sánchez-Dengra, Bárbara Merino, Virginia Dahan, Arik Gonzalez-Alvarez, Isabel García Arieta, Alfredo Gonzalez-Alvarez, Marta Bermejo, Marival |
| author2_role |
author author author author author author author |
| dc.contributor.none.fl_str_mv |
Departamentos de la UMH::Ingeniería |
| dc.subject.none.fl_str_mv |
candesartan cilexetil IVIVC bioequivalence BCS predictive in vivo-dissolution CDU::6 - Ciencias aplicadas::62 - Ingeniería. Tecnología |
| topic |
candesartan cilexetil IVIVC bioequivalence BCS predictive in vivo-dissolution CDU::6 - Ciencias aplicadas::62 - Ingeniería. Tecnología |
| description |
The main objective of this investigation was to develop an in vitro–in vivo correlation (IVIVC) for immediate release candesartan cilexetil formulations by designing an in vitro dissolution test to be used as development tool. The IVIVC could be used to reduce failures in future bioequivalence studies. Data from two bioequivalence studies were scaled and combined to obtain the dataset for the IVIVC. Two-step and one-step approaches were used to develop the IVIVC. Experimental solubility and permeability data confirmed candesartan cilexetil. Biopharmaceutic Classification System (BCS) class II candesartan average plasma profiles were deconvoluted by the Loo-Riegelman method to obtain the oral fractions absorbed. Fractions dissolved were obtained in several conditions in USP II and IV apparatus and the results were compared calculating the f2 similarity factor. Levy plot was constructed to estimate the time scaling factor and to make both processes, dissolution and absorption, superimposable. The in vitro dissolution experiment that reflected more accurately the in vivo behavior of the products of candesartan cilexetil employed the USP IV apparatus and a three-step pH buffer change, from 1.2 to 4.5 and 6.8, with 0.2% of Tween 20. This new model was able to predict the in vivo differences in dissolution and it could be used as a risk-analysis tool for formulation selection in future bioequivalence trials. |
| publishDate |
2020 |
| dc.date.none.fl_str_mv |
2020 2025 2025 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article |
| format |
article |
| dc.identifier.none.fl_str_mv |
https://hdl.handle.net/11000/34728 |
| url |
https://hdl.handle.net/11000/34728 |
| dc.language.none.fl_str_mv |
Inglés |
| language_invalid_str_mv |
Inglés |
| dc.relation.none.fl_str_mv |
https://doi.org/10.3390/pharmaceutics12070633 |
| dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess Attribution-NonCommercial-NoDerivatives 4.0 Internacional http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| eu_rights_str_mv |
openAccess |
| rights_invalid_str_mv |
Attribution-NonCommercial-NoDerivatives 4.0 Internacional http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| dc.format.none.fl_str_mv |
application/pdf 21 application/pdf |
| dc.publisher.none.fl_str_mv |
MDPI |
| publisher.none.fl_str_mv |
MDPI |
| dc.source.none.fl_str_mv |
reponame:REDIUMH. Depósito Digital de la UMH instname:Universidad Miguel Hernández de Elche |
| instname_str |
Universidad Miguel Hernández de Elche |
| reponame_str |
REDIUMH. Depósito Digital de la UMH |
| collection |
REDIUMH. Depósito Digital de la UMH |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869407993281380352 |
| score |
15.811543 |